Heart failure and anemia in patients with acute myocardial infarction
Abstract
About the Authors
T. Yu. KalyutaRussian Federation
R. E. Lubeznov
Russian Federation
O. V. Orlikova
Russian Federation
Yu. G. Schwartz
Russian Federation
References
1. Арутюнов Г.П. Анемия у больных с ХСН. // Сердечная недостаточность. 2003. Т. 4, № 5. С. 224-228.
2. Дэнхэм М. Дж., Чанарин И. Болезни крови у пожилых: Пер. с англ. М.: Медицина, 1989. 352 с.
3. Кузьмин В.П. Гомеостаз при остром нарушении коронарного кровообращения (1970-2000 гг.) и пути улучшения диагностики на догоспитальном этапе: Автореф. дис.... канд. мед. наук. Самара, 2003. 23 с.
4. Сыркин А.Л. Инфаркт миокарда: 3-е изд., перераб. и доп. М.: Медицинское информационное агентство, 2003. 466 с.
5. Зубкова А.А. Ближайшие и отдаленные последствия тромболитической терапии у больных острым инфарктом миокарда: Автореф. дис.... канд. мед. наук. Ростов-на-Дону, 2003. 21 с.
6. Al Falluji N., Lawrence-Nelson J., Kostis J.B., et al. Myocardial Infarction Data Acquisition system (MIDAS #8) Study Group. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. // Am Heart J. 2002. Vol. 144. P. 636-41.
7. Antman E., Cooper H., McKinlay S. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomized controlled trial. // Lancet. 2002. Vol. 360. P. 1955-1963.
8. Boneu В., Fernandez F. The role of the hematocrit in bleeding. // Transfus Med Rev. 1987. Vol. 1, N 3. P. 182-185.
9. De Valk В., Marx J.J. Iron, atherosclerosis, and ischemic heart disease. // Arch Intern Med. 1999. Vol. 159. P. 1542.
10. Kleiman N.S., White H.D., Ohman E.M., et al. Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. // Circulation. 1994. Vol. 90. P. 2658-2665.
11. Kupari M., Lindroos M., Iivanainen A.M., et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. // J Intern Med. 1997. Vol. 241. P. 387-394.
12. Goodnough L.T., Bach R.G. Anemia, Transfusion, and Mortality. // The New England Journal of Medicine. 2001. Vol. 345. P. 1272-1274.
13. Salonen J., Nyyssonen K., Korpela H. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnishmen. // Circulation. 1992. Vol. 86. P. 803-811.
14. Marchais S.J., Guerin A.P., Pannier В., London G.M. Pathophysiology of anaemia: focus on the heart and blood vessels. // Nephrol Dial Transplant. 2000. Vol. 15. P. 14-18.
15. White H. The Hirulog and Early Reperfusion or Occlusion (HERO-2) Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. // Lancet. 2001. Vol. 358. P. 1855-1863.
Review
For citations:
Kalyuta T.Yu., Lubeznov R.E., Orlikova O.V., Schwartz Yu.G. Heart failure and anemia in patients with acute myocardial infarction. Russian Journal of Cardiology. 2005;(1):16-19. (In Russ.)